Mode
Text Size
Log in / Sign up

Respiratory biofeedback and neurofeedback offer potential frameworks for managing multi-component dyspnea in COPD patientsNew ways to manage breathing struggles in COPD patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize dyspnea as a multi-component sensation; note neurofeedback is not yet an established treatment for COPD.

This perspective piece presents a conceptual model for managing dyspnea in patients with Chronic Obstructive Pulmonary Disease (COPD). The authors argue that dyspnea is not a monolithic sensation but comprises at least three partially dissociable components: air hunger, breathing effort, and chest tightness. By identifying these distinct components, the authors suggest that targeted interventions may be more effective.

The synthesis suggests that biofeedback may be relevant for modifying breathing patterns and investigating effects on perceived control, autonomic regulation, and affective responses to respiratory signals. However, the authors explicitly state that neurofeedback is not currently an established treatment for dyspnea. It is presented as a plausible area for future translational research rather than a current clinical standard.

A primary limitation of this work is its status as a hypothesis-generating conceptual model rather than a systematic review or clinical trial. The authors do not provide data on the cognitive-affective mechanisms of action. Clinical application is currently limited to providing a framework for understanding dyspnea components and identifying potential future research avenues in pulmonary rehabilitation.

How this fits prior evidence

This perspective addresses a gap in the management of COPD symptoms by proposing a multi-component model for dyspnea. While previous coverage noted that digital interventions show inconsistent results for medication adherence in chronic diseases, this conceptual model focuses on physiological and psychological components of breathing. It does not directly relate to findings regarding caregiver health literacy or the risks associated with comorbid Atrial Fibrillation.

Living with Chronic Obstructive Pulmonary Disease (COPD) often means dealing with dyspnea, the medical term for the distressing feeling of being unable to breathe deeply enough. This feeling is complex because it involves three distinct sensations: air hunger, the physical effort of breathing, and a tightening in the chest. Understanding these different parts helps experts figure out better ways to help patients feel more comfortable.

A new conceptual model suggests that biofeedback could play a role in treatment. Biofeedback works by giving people real-time information about their body's signals so they can learn to change their breathing patterns and gain a sense of control. While neurofeedback is not yet an established treatment for these symptoms, it is being looked at as a promising area for future research.

Because this is a conceptual model rather than a clinical trial, the results are not yet ready for everyday use in clinics. However, it provides a helpful framework for doctors and therapists to think about how they can help patients manage their breathing more effectively through new technology.

What this means for you:
Biofeedback may help COPD patients manage different sensations of shortness of breath by improving control.

Common questions

What is dyspnea?

Dyspnea is the medical term for the feeling of shortness of breath. In patients with COPD, this sensation is not just one feeling. It actually involves three different parts: air hunger, the physical effort required to breathe, and a tightening in the chest.

How does biofeedback help with breathing?

Biofeedback can provide information about your body's signals so you can learn to change your breathing patterns. It may help patients feel more in control of their breathing and improve how they respond to the physical sensations of shortness of breath.

Is neurofeedback a proven treatment for COPD?

No, neurofeedback is not currently an established treatment for dyspnea. While it is considered a plausible area for future research and study, it is not yet a standard part of pulmonary rehabilitation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Dyspnea in chronic obstructive pulmonary disease (COPD) is often treated as the perceptual consequence of altered airflow, lung volume, gas exchange, or work of breathing. Yet breathlessness is not a unitary symptom or a direct readout of pulmonary dysfunction. It comprises at least three partially dissociable sensations-air hunger, breathing effort, and chest tightness-with distinct physiological triggers and affective salience. Current models suggest that conscious breathlessness emerges from the interaction of respiratory motor drive, corollary discharge, sensory afferent feedback, central integration, and higher-order interoceptive inference. In COPD, this framework helps explain why dyspnea may diverge from spirometric impairment and why symptom burden can remain high despite appropriate treatment. This Perspective develops a hypothesis-generating conceptual model for pulmonary rehabilitation, rather than a systematic or scoping review. We argue that respiratory biofeedback may be relevant not only because it can modify breathing pattern, but also because it may help test whether changing perceived control, autonomic regulation, and affective responses to respiratory signals can influence rehabilitation-relevant outcomes. Our recent pilot trial in late-stage COPD is compatible with this interpretation, but it did not directly test cognitive-affective mechanisms of action. From this perspective, neurofeedback should not be considered an established treatment for dyspnea, but a plausible future translational research question for selected highly symptomatic patients. Extension of this framework beyond COPD to other chronic respiratory diseases requires condition-specific validation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.